Algorae Pharmaceuticals Limited
LVCLF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $13 | $17 | $19 | $9 |
| - Cash | $0 | $3 | $4 | $4 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $13 | $14 | $14 | $5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | 198% | 1,134% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | 100% | 98.7% | 78.2% |
| EBITDA | $0 | -$2 | -$2 | -$1 |
| % Margin | – | -1,261.3% | -3,619.7% | -42,848.3% |
| Net Income | -$1 | -$2 | -$2 | -$2 |
| % Margin | – | -1,673.8% | -5,016.3% | -57,483.1% |
| EPS Diluted | -0.001 | -0.001 | -0.002 | -0.002 |
| % Growth | 61.5% | 18.8% | 27.3% | – |
| Operating Cash Flow | -$0 | -$2 | -$2 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$2 | -$2 | -$2 |